Part 10 · Myth 48

PRP will regrow my disc and avoid surgery

Partial Truth

What Patients Say
My physiotherapist mentioned PRP. It's made from my own blood, so it's natural and safe. If growth factors can repair a tendon, surely they can rebuild my disc and mean I never need surgery?

Where Did This Come From?

PRP — platelet-rich plasma — is produced by drawing a patient's blood, spinning it in a centrifuge, and concentrating the platelet layer. Platelets release growth factors: proteins involved in wound healing, tissue repair, and inflammation modulation. For certain conditions — chronic Achilles tendinopathy, lateral epicondylitis, mild-to-moderate knee osteoarthritis — there is reasonable evidence that PRP can reduce pain and support recovery.

The extrapolation to disc regeneration is understandable but incorrect in an important way.

Tendons and joint linings have far better blood supply than intervertebral discs. Growth factors work partly by attracting repair cells — and attracting cells through diffusion alone, into an avascular, mechanically loaded, increasingly hostile disc environment, is a different biological challenge. There is also no standardised PRP product. Leukocyte-rich versus leukocyte-poor formulations, platelet concentration, activation status, imaging guidance, injection location, number of injections, and patient selection all vary significantly across clinics — and across studies. Comparing "PRP" in one study to "PRP" in another is often comparing quite different products.

The clinical evidence for intradiscal PRP in discogenic pain is early and mixed. Some trials have shown statistically significant improvements in pain and function scores at 12 months compared to placebo. A crossover RCT found PRP superior to saline at 12 months. But another well-designed RCT found no benefit over saline in patients without Modic changes on MRI — suggesting that patient selection is the critical variable and that results in appropriately selected patients may not generalise to all patients with disc pain.

The AAOS (American Academy of Orthopaedic Surgeons) describes PRP as promising in some contexts while noting that evidence is still insufficient to make broad recommendations. No guideline body endorses intradiscal PRP as a standard treatment for disc disease.

What patients consistently confuse: pain reduction is not the same as structural regeneration. If PRP reduces discogenic pain — which some evidence suggests it may, in selected patients — that is clinically valuable but it is not the same as regrowing a collapsed disc or reversing stenosis. A disc that was 30% of its original height before the injection remains 30% after it.

The Verdict

PRP may reduce pain and modulate inflammation in selected patients with discogenic pain. It does not regenerate discs. It does not reliably avoid surgery in patients who genuinely need it. It is not a universal treatment.

Take-Home MessagePRP is not magic and it is not a scam — it exists somewhere in between, and exactly where depends on your specific situation. For carefully selected patients with mild-to-moderate discogenic pain, adequate disc height, and symptoms that correlate with Modic changes, it may have genuine value as part of a multimodal treatment plan. For patients with severe disc collapse, significant canal stenosis, or neurological deficit, it is not the answer and should not delay appropriate evaluation. The question to ask is not "will PRP help me?" but "am I the kind of patient for whom the evidence suggests PRP might help?"

What To Do Instead

Have a spine specialist — not the clinic selling the injection — assess whether your pathology is the kind that preliminary evidence supports for intradiscal PRP (mild-to-moderate discogenic pain, Modic changes, adequate disc height)
Understand that PRP preparations are not standardised — ask the provider about their specific protocol, platelet concentration, imaging guidance, and outcome data
Use PRP, if appropriate, as an adjunct to a rehabilitation programme — not as a standalone cure
Be cautious of package deals: multiple injections bundled upfront, cash-pay-only pricing, and promises of "regeneration" rather than "symptom modulation"

Yellow Flags — Worth Monitoring

Clinic offering PRP alongside a long list of conditions — liver disease, hair loss, neurological disorders, and back pain — PRP has different evidence quality for different applications
No imaging guidance for an intradiscal injection — fluoroscopy or CT guidance is not optional, it is a safety standard

Red Flags — Seek Independent Advice

PRP offered as an alternative to surgical treatment for cauda equina syndrome, rapidly progressive neurological deficit, or significant myelopathy — these are emergencies, not regenerative medicine indications
Any claim that PRP is FDA-approved for disc disease — it is not

Reference Note

American Academy of Orthopaedic Surgeons (AAOS). "Platelet-Rich Plasma (PRP)." OrthoInfo.org. (PRP described as promising with evidence still lacking for many claims; better support for chronic tendon injuries and mild-to-moderate knee osteoarthritis.)
Tuakli-Wosornu YA et al., "Lumbar intradiskal platelet-rich plasma therapy," PM&R, 2016. Navani A et al., multicenter crossover RCT, intradiscal PRP vs placebo, Regional Anesthesia and Pain Medicine, 2021. Peng BG et al., Pain Physician, 2023.

← Back to all myths